TRULUCK JOSEPH (COO and CFO) received a stock award from ADIAL PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 5/25/2023ACC: 0001213900-23-043133
Officer· COO and CFO
Since Jul 2018
+282.50K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
282.50K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+157.50K
Price / share
—
Trade value
—
% of position
146.3%
5/23/2023
107.64K→265.14K
Total
Net shares
+157.50K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/23/2023 | A · Award | +157.50K | — | — | 146.3% | 107.64K | 265.14K |
| Total | +157.50K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
125K shares
Shares
+125K
Strike price
0.3025
Held after
125K
Exercisable
—
5/23/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock125K shares | 5/23/2023 | A · Award | +125K | 0.3025 | — | 125K |